Fund+ — Full Portfolio

Astrivax Therapeutics is a clinical-stage biopharmaceutical company developing immunotherapies to treat virus-driven cancers, particularly HPV16-associated cancers like cervical and head and neck cancer.

BiotechDigital HealthHealthtechMedical Devices

HCHanne Callewaert(Founder)in

Co-investorsKOKorysPMPMVV-V-Bio Ventures

Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision.

BiotechDeep TechHealthtechMedical DevicesParis, FR

Co-investorsKUKurma PartnersSESeroba Life SciencesV-V-Bio VenturesBPBpifranceINInvusNONovo Holdings+1 more

VIB is a non-profit research institute focused on strategic basic research in life sciences, operating in partnership with five Flemish universities.

BiotechDeep TechMedical DevicesGhent, BE

JSJan Steyaert(Founder (Scientific))inCVCedric Ververken(CEO)in

Co-investorsCACapricorn Venture PartnersPMPMVQUQuest for GrowthV-V-Bio VenturesBIBioGeneration Ventures

Egle Therapeutics develops targeted immunotherapy drugs by leveraging regulatory T cell (Treg) biology to treat autoimmune diseases and cancer.

Biotech

Fiorella Kotsias(Chief Scientific Officer)inBernard Vanhove(Chief Development Officer)in

BoardMDMichel Detheux(Chairman)in

Co-investorsEQEQT Life SciencesJDJDRF T1D Fund

EPICS Therapeutics develops RNA epigenetics-based cancer treatments, focusing on METTL3 inhibitors for cancers including non-small cell lung cancer, pancreatic cancer, ovarian cancer, and colorectal cancer where existing therapies are insufficient.

BiotechDigital HealthMedical Devices

Co-investorsNENewton Biocapital

Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development.

BiotechDeep TechMedical DevicesNiel, BE

Co-investorsPMPMVBOBoehringer Ingelheim Venture Fund

ExeVir develops multi-specific VHH antibody therapies to treat infectious diseases, immunological conditions, and oncology, with a focus on immunocompromised populations.

BiotechDeep TechDigital HealthHealthtechMedical DevicesGhent, BE

Xavier Saelens(Scientific Founder)Nico Callewaert(Scientific Founder)inMike Garrett(Chief Executive Officer)

Co-investorsV-V-Bio VenturesSASambrinvestUCUCB VenturesVIVIBVIVIVES Partners

EyeD Pharma develops pharmaceutical treatments focused on ophthalmology, particularly for glaucoma and related eye conditions.

BiotechHealthtechMedical DevicesLiège, BE

MMMélanie Mestdagt(Chief Executive Officer & Co-Founder)inMFMarc Foidart(Co-Founder)inJRJean-Marie Rakic(Co-Founder)

Co-investorsWAWallonie Entreprendre

Immunic is a clinical-stage biopharmaceutical company developing oral small molecule treatments for neurologic and autoimmune diseases with unmet medical needs.

BiotechHealthtechMedical DevicesNew York City, US

Dr. Hella Kohlhof(Co-Founder, Chief Scientific Officer)Erik Lundgren(Chief Executive Officer)inJTJason Tardio(President and Chief Operating Officer)inMAMichael A. Panzara(Chief Medical Officer)in

Indigo is developing an implantable continuous multi-metabolite monitoring (CMM) sensor based on silicon photonics that measures metabolites such as glucose, ketone, and lactate in real time, with data shown via a smartphone app.

Digital HealthHardwareMedical Devices

DDDanaë Delbeke(CTO and Founder)in

Co-investorsIMimec.xpand

Minoryx is a registration-stage biotech company developing novel therapies for severe, orphan genetic diseases of the central nervous system, with a lead compound (leriglitazone) in clinical trials for conditions including cerebral adrenoleukodystrophy, Friedreich's Ataxia, and Rett syndrome.

BiotechDeep TechHealthtechMedical DevicesMataró, ES

MMMarc Martinell(Co-Founder & Chief Executive Officer)in

Co-investorsCHChiesi VenturesCRCriteria Bio VenturesINInvivo Capital PartnersKUKurma PartnersRORoche Venture FundYSYsios Capital+2 more

Novadip develops regenerative medicine treatments using its 3M3 tissue regeneration platform to address conditions requiring bone and tissue repair, including spinal fusion, cancer recovery, and complex fractures.

BiotechDeep TechHealthtechMedical DevicesLouvain, BE

DDDr. Denis Dufrane(Founder & Professor)in

BoardEric Paul Pâques(Chairman)

Co-investorsNENew Science VenturesVIVIVES Partners

Ona provides cloud-based agent infrastructure that runs developer tasks in isolated environments while laptops are closed, automating workflow execution through events, schedules, and pull requests.

AI & Machine LearningCloud ComputingDeveloper Tools

Co-investorsBRBright Pixel CapitalCRCrane Venture PartnersPEPebblebedPRPreston-Werner VenturesALAlta Life SciencesASAsabys Partners+4 more

Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma.

BiotechHealthtechMedical Devices

Co-investorsKOKorysMÉMérieux Equity PartnersYSYsios CapitalALAlta Life SciencesASAsabys PartnersBPBpifrance+2 more

TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht.

BiotechMedical DevicesUtrecht, NL

CMCoen Maas(Co-founder)inSDSteven de Maat(Chief Scientific Officer)inMarc van Moorsel(Director of Operations)inKVKristof Vercruysse(Chief Executive Officer)inRDRob Dekker(Vice President CMC)inFilip Van den Wyngaert(Vice President Asset Management)in

Co-investorsANAndera PartnersCUCurie CapitalHAHadean VenturesRORotripBIBioGeneration VenturesINInkef+1 more

The page is a placeholder shell showing only cookie/consent notices for embedded third-party content (Vimeo, YouTube, reCAPTCHA, social media) and contains no substantive information about the company.

DSDominik Schumacher(Founder)in

Co-investorsANAndera PartnersBIBioMedPartnersFRFrazier Life SciencesNENextech InvestOCOCCIDENT